Shandong Weigao Orthopaedic Device Co. Ltd. A (688161) — Capital Reinvestment Ratio
Shandong Weigao Orthopaedic Device Co. Ltd. A (688161) has a Capital Reinvestment Ratio of 0.07x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥415.42 Million) in capital expenditures (CN¥27.09 Million). See 688161 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shandong Weigao Orthopaedic Device Co. Ltd. A Capital Reinvestment Ratio (2019–2025)
This chart tracks Shandong Weigao Orthopaedic Device Co. Ltd. A's Capital Reinvestment Ratio across 7 annual periods.
Annual Capital Reinvestment Ratio for Shandong Weigao Orthopaedic Device Co. Ltd. A (2019–2025)
Year-by-year Capital Reinvestment Ratio for Shandong Weigao Orthopaedic Device Co. Ltd. A from 2019 to 2025. For live market cap and broader valuation context, see market cap of Shandong Weigao Orthopaedic Device Co. L.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.07x | CN¥415.42 Million | CN¥27.09 Million | ▼ -26.5% |
| 2024 | 0.09x | CN¥274.19 Million | CN¥24.34 Million | ▼ -75.3% |
| 2023 | 0.36x | CN¥119.44 Million | CN¥42.98 Million | ▲ +58.1% |
| 2022 | 0.23x | CN¥508.56 Million | CN¥115.76 Million | ▲ +59.6% |
| 2021 | 0.14x | CN¥788.25 Million | CN¥112.41 Million | ▲ +85.2% |
| 2020 | 0.08x | CN¥644.12 Million | CN¥49.59 Million | ▲ +42.1% |
| 2019 | 0.05x | CN¥534.15 Million | CN¥28.94 Million | — |